Sonoma Pharmaceuticals Q1 EPS $(0.07) Misses $(0.06) Estimate, Sales $3.39M Miss $3.94M Estimate
Portfolio Pulse from Benzinga Newsdesk
Sonoma Pharmaceuticals (NASDAQ:SNOA) reported Q1 EPS of $(0.07), missing the $(0.06) estimate. Sales were $3.39M, below the $3.94M estimate. Despite the misses, EPS improved from $(0.29) last year, while sales slightly decreased from $3.43M.
August 08, 2024 | 10:13 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Sonoma Pharmaceuticals reported Q1 EPS of $(0.07), missing the $(0.06) estimate. Sales were $3.39M, below the $3.94M estimate. Despite the misses, EPS improved from $(0.29) last year, while sales slightly decreased from $3.43M.
The earnings and sales misses are likely to negatively impact the stock price in the short term. However, the improvement in EPS from last year may provide some support.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100